Tom Keith-Roach, president of AstraZeneca UK, said on Wednesday that they are scaling up to release over 2 million doses of their coronavirus vaccine in the UK very shortly, as reported by Reuters.
"Production of vaccine is 3-4 month process."
"We can give high visibility on supply timetable through to the end of Q1 this year."
"Hope to be 2 million doses a week on or before mid-February."
"Process optimisation may make more than 2 million doses a week for UK possible, but can't commit to that."
"COVID outbreaks are hindering vaccine development workforce."
"We have requested that vaccine developers and trial staff are prioritised for receiving a shot."
The UK's FTSE pared its earlier losses after these remarks and was last seen posting small gains at 6,756.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.